Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension

M A Rossi1

  • 1Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil. marossi@fmrp.usp.br

Journal of Hypertension
|October 30, 1998
PubMed

Insights

Chronic arterial hypertension leads to increased fibrosis and collagen in the heart, contributing to left ventricular hypertrophy and dysfunction. This study highlights changes in the myocardial connective tissue matrix in hypertensive hearts.

Area of Science:

  • Cardiovascular Pathology
  • Connective Tissue Biology
  • Cardiac Physiology

Background:

  • Chronic arterial hypertension is a major cause of left ventricular hypertrophy (LVH).
  • LVH involves changes in myocardial structure, including fibrosis and alterations in the connective tissue matrix.
  • Understanding these changes is crucial for predicting cardiac function and risk.

Purpose of the Study:

  • To investigate the pathological fibrosis and connective tissue matrix in human hearts with left ventricular hypertrophy due to chronic arterial hypertension.
  • To correlate the extent of fibrosis and matrix changes with the degree of cardiac hypertrophy.

Main Methods:

  • Study included 17 human hearts: 4 controls and 13 with systemic hypertension categorized by heart weight.
  • A cell-maceration method was used to evaluate the myocardial connective matrix in 3D.
  • Conventional light microscopy and morphometric studies were also performed.

Main Results:

  • Hypertensive hearts showed a progressive increase in myocyte diameter and fibrosis volume fraction with increasing heart weight.
  • A marked increase in pericellular collagen (endomysial matrix) and perimysial matrix was observed.
  • Progressive disarray of the myocardial connective tissue skeleton correlated with increasing cardiac hypertrophy.

Conclusions:

  • Progressive collagen accumulation in LVH contributes to ventricular dysfunction (diastolic/systolic) and increased arrhythmogenic risk in hypertensive hearts.
  • The cell-maceration method is effective for studying myocardial collagen organization in health and disease.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...